ZYNE Stock Zooms 430% This Year, Analyst Sees Further Rally
ZYNE stock has been making big moves this year and has gained almost 430% since the year began. In fact, Zynerba Pharmaceuticals (NASADAQ:ZYNE)'s stock has doubled over the past month alone amid a couple of ... [Read]
Zenabis strengthens its leadership team with new CEO, Andrew Grieve
Co-Founder and former CEO Rick Brar will continue to contribute as a Special Advisor VANCOUVER, Jan. 21, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV:ZENA) announced today that it has appointed Andrew Grieve as Chief Executive Officer, effective immediately. Rick Brar, Zenabis' ... [Read]